Associated Papers
Transcriptomic landscape of CD8+ and CD4 + T-LGL leukemia revealed the distinct impact of STAT3 and STAT5B activating mutations.
Calabretto G et al.
Leukemia, 2025
40721648 (PubMed )
Supplement: 41375_2025_2708_MOESM3_ESM.xlsx › Suppl_table_2
Comprehensive Evaluation of a 1021-Gene Panel in FFPE and Liquid Biopsy for Analytical and Clinical Use.
Meintani A et al.
International Journal of Molecular Sciences, 2025
40649709 (PubMed )
Supplement: ijms-26-05930-s001.zip › Supplementary_Table_2_and_Figure_S1.xlsx › Table_S3
TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era.
Landsburg DJ et al.
Blood Advances, 2023
37851898 (PubMed )
Supplement: BLOODA_ADV-2023-011384-mmc1.pdf
Three Chinese pedigrees of A20 haploinsufficiency: clinical, cytokine and molecular characterization.
Tian Y et al.
Frontiers in Immunology, 2022
Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment.
Yu MP et al.
World Journal of Pediatrics : Wjp, 2020
Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20.
Chen Y et al.
Frontiers in Immunology, 2020
33101300 (PubMed )
Supplement: Data_Sheet_3.PDF
Novel Heterogeneous Mutation of TNFAIP3 in a Chinese Patient with Behçet-Like Phenotype and Persistent EBV Viremia.
Dong X et al.
Journal of Clinical Immunology, 2019
Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20).
Zheng C et al.
Inflammatory Bowel Diseases, 2018
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
Juskevicius D et al.
Journal of Hematology & Oncology, 2017
28302137 (PubMed )
Supplement: 13045_2017_438_MOESM1_ESM.xlsx › Selected_mutations_2016.08.22
Select a paper to view details